Abstract
Actin plays central roles in cell motility through formation of the actin cytoskeleton. Recently, the very intriguing possibility that actin also contributes to processes in the cell nucleus has been emerging. To dissect its dynamics and functions, several actin-disrupting drugs have been widely and effectively employed. Among them, latrunculin-A has proved particularly useful, supplanting the classical drug cytochalasin-D. One reason is that latrunculin-A appears to bind only to actin monomers impairing the nucleotide exchange, the mode being simpler than with cytochalasin. This property may be especially crucial when studying actin functions as a monomer, as suggested for nuclear actin. Very importantly, actin mutations that cause cells to become resistant to the effects of latrunculin-A have been identified in budding yeast. However, it remains controversial as to whether all of the various phenotypes observed with latrunculin in mammalian cells more complicated than yeast are truly the consequence of its specific actions against actin. Here, we show that the expression of R183A D184A mutant β-actin specifically confers resistance to the effects of latrunculin-A on actin cytoskeleton formation and cell growth in HeLa cells. The established system provides a strong tool to address the various functions of actin in mammalian cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ayscough KR, Stryker J, Pokala N, Sanders M, Crews P and Drubin DG . (1997) J. Cell Biol., 137, 399–416.
Coué M, Brenner SL, Spector I, Korn ED . (1987) FEBS Lett., 213, 316–318.
Kimura T, Hashimoto I, Yamamoto A, Nishikawa M and Fujisawa J . (2000) Genes Cells, 5, 277–287.
Lamaze C, Fujimoto LM, Yin HL and Schmid SL . (1997) J. Biol. Chem., 272, 20332–20335.
Mitchson TJ and Cramer LP . (1996). Cell, 84, 371–379.
Morales M, Colicos MA and Goda Y . (2000). Neuron, 27, 539–550.
Morton WM, Ayscough KR and McLaughlin PJ . (2000). Nat. Cell Biol., 2, 376–378.
Ohmori H, Toyama S and Toyama S . (1992). J. Cell Biol., 116, 933–941.
Rando OJ, Zhao K and Crabtree GR . (2000). Trends Cell Biol., 10, 92–97.
Spector I, Shochet NR, Kashman Y and Groweiss A . (1983). Science, 219, 493–495.
Toyama S and Toyama S . (1984). Cell, 37, 609–614.
Wasser M and Chia W . (2000). Nat. Cell Biol., 2, 268–275.
Wertman KF, Drubin DG and Botstein D . (1992). Genetics, 132, 337–350.
Zhao K, Wang W, Rando OJ, Xue Y, Swiderek K, Kuo A and Crabtree GR . (1998). Cell, 95, 625–636.
Acknowledgements
We thank Dr S Toyama (Kyoto University) for providing pOTβ-actin, and T Yoshida, Y Nishikawa and K Matsuguchi for technical assistance. This work was supported in part by grants to MF from the Ministry of Education, Science, Sports and Culture of Japan, and from the Uehara Memorial Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fujita, M., Ichinose, S., Kiyono, T. et al. Establishment of latrunculin-A resistance in HeLa cells by expression of R183A D184A mutant β-actin. Oncogene 22, 627–631 (2003). https://doi.org/10.1038/sj.onc.1206173
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206173